【结 构 式】 |
【药物名称】Darifenacin, UK-88525-04(hydrobromide), UK-88525, Enablex 【化学名称】(S)-2-[1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide 【CA登记号】133099-04-4, 133099-07-7 (HBr salt) 【 分 子 式 】C28H30N2O2 【 分 子 量 】426.5635 |
【开发单位】Novartis (Proprietary), Pfizer (Originator) 【药理作用】RENAL-UROLOGIC DRUGS, Urinary Incontinence Therapy, Muscarinic M3 Antagonists |
合成路线1
【1】 Dcmn PJ, Matthews JG, et al.2003 Precnratian ofstable hrdate of a m~nrnrinic receptor anta8aoHt,(s)-2-[1-[2-(2,3-dihydrobenzofurarrSyl)ethyl}3-pyrrolid inyl}2,2-diphenylacetamide hydrate, W0 2003080599 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(V) | 66216 | 2-(1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetonitrile | C28H28N2O | 详情 | 详情 | |
(I) | 14494 | 2-[(3S)-1-[(4-methylphenyl)sulfonyl]tetrahydro-1H-pyrrol-3-yl]-2,2-diphenylacetonitrile | C25H24N2O2S | 详情 | 详情 | |
(II) | 66215 | 2,2-diphenyl-2-(pyrrolidin-3-yl)acetonitrile hydrobromide | C18H18N2.HBr | 详情 | 详情 | |
(III) | 14500 | 2-(2,3-dihydro-1-benzofuran-5-yl)acetic acid | 69999-16-2 | C10H10O3 | 详情 | 详情 |
(IV) | 66215 | 2,2-diphenyl-2-(pyrrolidin-3-yl)acetonitrile hydrobromide | C18H18N2.HBr | 详情 | 详情 |
合成路线2
Darifenacin can be obtained by three related ways: 1) The decarboxylation of (2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid (I) by heating at 154 C in cyclohexanol/2-cyclohexenone gives 3(R)-hydroxypyrrolidine (II), which is N-tosylated with p-toluenesulfonyl chloride and pyridine yielding (III). The reaction of (III) with methyl p-toluenesulfonate, triphenylphosphine and diethyl azodicarboxylate (DEAD) in THF affords 1-tosyl-3(S)-(tosyloxy)pyrrolidine (IV), which is condensed with 2,2-diphenylacetonitrile (V) by means of NaH in refluxing toluene to give 2,2-diphenyl-2-[1-(p-toluenesulfonyloxy)pyrrolidin-2(S)-yl]acetonitrile (VI). Elimination of the tosyl group of (VI) with HBr and phenol in refluxing water yields 2,2-diphenyl-2-[2(S)-pyrrolidinyl]acetonitrile (VII), which by treatment with 95% H2SO4 at 100 C is converted into the corresponding acetamide (VIII). The condensation of (VIII) with 5-(chloroacetyl)-2,3-dihydrobenzofuran (IX) by means of potassium carbonate in industrial methylated spirits affords the ketonic amide (X), which is finally reduced with H2 over Pd/C in acetic acid. The intermediate 5-(chloroacetyl)-2,3-dihydrobenzofuran (IX) has been obtained by Friedel-Crafts condensation of 2,3-dihydrobenzofuran (XI) with chloroacetyl chloride by means of AlCl3 in dichloromethane. 3) The condensation of 5-(2-bromoethyl)benzofuran (XV), with the previously obtained acetamide (VIII) by means of K2CO3 in refluxing acetonitrile affords the condensation product (XVI), which is hydrogenated with H2 over Pd/C in hot acetic acid.
【1】 Graul, A.; Castaner, J.; Darifenacin. Drugs Fut 1996, 21, 11, 1105. |
【2】 Cross, P.E.; Mackenzie, A.R. (Pfizer Inc.); Pyrrolidine derivs. AU 9051402; EP 0388054; JP 1990282360; JP 1995149640; US 5096890 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 14489 | (2S,4R)-4-hydroxytetrahydro-1H-pyrrole-2-carboxylic acid; L-Hydroxyproline | 51-35-4 | C5H9NO3 | 详情 | 详情 |
(II) | 14490 | (3R)tetrahydro-1H-pyrrol-3-ol; R-3-hydroxypyrrolidine | 2799-21-5 | C4H9NO | 详情 | 详情 |
(III) | 14491 | (3R)-1-[(4-methylphenyl)sulfonyl]tetrahydro-1H-pyrrol-3-ol | C11H15NO3S | 详情 | 详情 | |
(IV) | 14492 | (3S)-1-[(4-methylphenyl)sulfonyl]tetrahydro-1H-pyrrol-3-yl 4-methylbenzenesulfonate | C18H21NO5S2 | 详情 | 详情 | |
(V) | 14493 | alpha-phenylbenzeneacetonitrile; 2,2-diphenylacetonitrile; Diphenylacetonitrile | 86-29-3 | C14H11N | 详情 | 详情 |
(VI) | 14494 | 2-[(3S)-1-[(4-methylphenyl)sulfonyl]tetrahydro-1H-pyrrol-3-yl]-2,2-diphenylacetonitrile | C25H24N2O2S | 详情 | 详情 | |
(VII) | 14495 | 2,2-diphenyl-2-[(3S)tetrahydro-1H-pyrrol-3-yl]acetonitrile | C18H18N2 | 详情 | 详情 | |
(VIII) | 14496 | 2,2-diphenyl-2-[(3S)tetrahydro-1H-pyrrol-3-yl]acetamide | C18H20N2O | 详情 | 详情 | |
(IX) | 14497 | 2-chloro-1-(2,3-dihydro-1-benzofuran-5-yl)-1-ethanone | C10H9ClO2 | 详情 | 详情 | |
(X) | 14498 | 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)-2-oxoethyl]tetrahydro-1H-pyrrol-3-yl]-2,2-diphenylacetamide | C28H28N2O3 | 详情 | 详情 | |
(XI) | 14499 | 2,3-Dihydrobenzofuran; 2,3-dihydro-1-benzofuran | 496-16-2 | C8H8O | 详情 | 详情 |
(XII) | 14500 | 2-(2,3-dihydro-1-benzofuran-5-yl)acetic acid | 69999-16-2 | C10H10O3 | 详情 | 详情 |
(XIII) | 14501 | 2-(2,3-dihydro-1-benzofuran-5-yl)-1-ethanol | C10H12O2 | 详情 | 详情 | |
(XIV) | 14502 | 5-(2-bromoethyl)-2,3-dihydro-1-benzofuran | C10H11BrO | 详情 | 详情 | |
(XV) | 14503 | 5-(2-bromoethyl)-1-benzofuran | C10H9BrO | 详情 | 详情 | |
(XVI) | 14504 | 2-[(3S)-1-[2-(1-benzofuran-5-yl)ethyl]tetrahydro-1H-pyrrol-3-yl]-2,2-diphenylacetamide | C28H28N2O2 | 详情 | 详情 |